Table 5.
Comparison of Biochemical Indices Before and After the First TACE Treatment Between the TACE Plus Sorafenib and TACE Alone Treatment Groups
| Time | Group | TBIL (µmol/L) | ALT (µ/L) | AST (µ/L) | CHE (µ/L) | ALB (g/L) | AFP (µg/L) |
|---|---|---|---|---|---|---|---|
| TACE plus sorafenib (n=42) |
Before | 19.51± 3.94 | 55.11± 13.24 | 50.74± 11.69 | 4849.04± 701.91 | 32.13± 3.10 | 647.45± 268.52 |
| After | 19.88± 3.47 | 57.90± 14.00 | 53.56± 11.79 | 5023.99± 835.30 | 33.17± 2.99 | 229.34± 91.25 | |
| t | −5.013 | −23.261 | −69.888 | −7.962 | −46.706 | 15.247 | |
| p | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| TACE alone (n=43) | Before | 19.29± 4.23 | 55.45± 14.01 | 50.65± 11.88 | 4888.09± 693.62 | 31.95± 3.18 | 612.32± 272.14 |
| After | 25.97± 3.77 | 67.35± 14.46 | 60.97± 11.96 | 4013.95± 727.36 | 31.81± 3.07 | 326.55± 101.12 | |
| t | −95.2720 | −148.439 | −632.856 | 152.356 | 6.850 | 10.944 | |
| p | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 |
Note: Results are presented as mean ± SD.
Abbreviations: AFP, alpha-fetoprotein; ALB, albumin; ALT, alanine transaminase; AST, aspartate transaminase; CHE, cholinesterase; TACE, transarterial chemoembolization; TBIL, total bilirubin.